Kowalczyk P, Wilk M, Parul P, Szymczak M, Kramkowski K, Raj S
Materials (Basel). 2021; 14(19).
PMID: 34640121
PMC: 8510199.
DOI: 10.3390/ma14195725.
Kowalczyk P, Madej A, Paprocki D, Szymczak M, Ostaszewski R
Materials (Basel). 2020; 13(11).
PMID: 32486298
PMC: 7321437.
DOI: 10.3390/ma13112499.
Singh L, Avula S, Raj S, Srivastava A, Palnati G, Tripathi C
J Antibiot (Tokyo). 2017; 70(9):954-961.
PMID: 28634338
DOI: 10.1038/ja.2017.70.
Mojarrab M, Emami S, Delazar A, Tayarani-Najaran Z
Iran J Pharm Res. 2017; 16(1):221-229.
PMID: 28496477
PMC: 5423249.
Fajinmi O, Gruz J, Tarkowski P, Kulkarni M, Finnie J, van Staden J
Pharm Biol. 2017; 55(1):1249-1255.
PMID: 28262031
PMC: 6130550.
DOI: 10.1080/13880209.2017.1296470.
New dicoumarol sodium compound: crystal structure, theoretical study and tumoricidal activity against osteoblast cancer cells.
Rehman S, Ikram M, Khan A, Min S, Azad E, Hofer T
Chem Cent J. 2013; 7:110.
PMID: 23819586
PMC: 3716688.
DOI: 10.1186/1752-153X-7-110.
Synthesis, characterization, in vitro antimicrobial, and U2OS tumoricidal activities of different coumarin derivatives.
Rehman S, Ikram M, Baker R, Zubair M, Azad E, Min S
Chem Cent J. 2013; 7(1):68.
PMID: 23587363
PMC: 3668295.
DOI: 10.1186/1752-153X-7-68.
Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents.
Matos M, Vazquez-Rodriguez S, Santana L, Uriarte E, Fuentes-Edfuf C, Santos Y
Molecules. 2013; 18(2):1394-404.
PMID: 23348993
PMC: 6269744.
DOI: 10.3390/molecules18021394.
Sequential posttranslational modifications program FEN1 degradation during cell-cycle progression.
Guo Z, Kanjanapangka J, Liu N, Liu S, Liu C, Wu Z
Mol Cell. 2012; 47(3):444-56.
PMID: 22749529
PMC: 3518404.
DOI: 10.1016/j.molcel.2012.05.042.
Biological activities of novel gyrase inhibitors of the aminocoumarin class.
Anderle C, Stieger M, Burrell M, Reinelt S, Maxwell A, Page M
Antimicrob Agents Chemother. 2008; 52(6):1982-90.
PMID: 18347114
PMC: 2415755.
DOI: 10.1128/AAC.01235-07.
New Samarium(III), Gadolinium(III), and Dysprosium(III) Complexes of Coumarin-3-Carboxylic Acid as Antiproliferative Agents.
Kostova I, Momekov G, Stancheva P
Met Based Drugs. 2008; 2007:15925.
PMID: 18274603
PMC: 1894889.
DOI: 10.1155/2007/15925.
Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis.
Flatman R, Eustaquio A, Li S, Heide L, Maxwell A
Antimicrob Agents Chemother. 2006; 50(4):1136-42.
PMID: 16569821
PMC: 1426943.
DOI: 10.1128/AAC.50.4.1136-1142.2006.
Mass spectrometric characterization of a three-enzyme tandem reaction for assembly and modification of the novobiocin skeleton.
Pi N, Freel Meyers C, Pacholec M, Walsh C, Leary J
Proc Natl Acad Sci U S A. 2004; 101(27):10036-41.
PMID: 15218104
PMC: 454160.
DOI: 10.1073/pnas.0403526101.
Antimicrobial and DNA gyrase-inhibitory activities of novel clorobiocin derivatives produced by mutasynthesis.
Galm U, Heller S, Shapiro S, Page M, Li S, Heide L
Antimicrob Agents Chemother. 2004; 48(4):1307-12.
PMID: 15047534
PMC: 375324.
DOI: 10.1128/AAC.48.4.1307-1312.2004.
Identification of the coumermycin A(1) biosynthetic gene cluster of Streptomyces rishiriensis DSM 40489.
Wang Z, Li S, Heide L
Antimicrob Agents Chemother. 2000; 44(11):3040-8.
PMID: 11036020
PMC: 101600.
DOI: 10.1128/AAC.44.11.3040-3048.2000.